Re: Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm

Re: Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm

EDITORIAL COMMENT The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large population-based randomized trial designed and sponsored by the National Cancer Institute to determine the effects of screening on cancer-related mortality and secondary endpoints in men and wome...

Full description

Bibliographic Details
Main Author:	Özgür Yaycıoğlu
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2017-03-01
Series:	Journal of Urological Surgery
Online Access:	http://jurolsurgery.org/article_14738/Re-Prognostic-Significance-Of-Digital-Rectal-Examination-And-Prostate-Specific-Antigen-In-The-Prostate-Lung-Colorectal-And-Ovarian-plco-Cancer-Screening-Arm

Similar Items

Re: Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
by: Özgür Yaycıoğlu
Published: (2018-06-01)

Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
by: Xin Xu
Published: (2020-07-01)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
by: Susan R. Sturgeon, et al.
Published: (2017-08-01)

Re: Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance
by: Özgür Yaycıoğlu
Published: (2016-09-01)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
by: Amelia Smith, et al.
Published: (2018-01-01)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
by: Leitzmann Michael F, et al.
Published: (2009-03-01)

Re: Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique
by: Özgür Yaycıoğlu
Published: (2016-06-01)

Detection method has independent prognostic significance in the PLCO lung screening trial
by: James P. Long, et al.
Published: (2023-08-01)

Re: Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis
by: Özgür Yaycıoğlu
Published: (2016-12-01)

Re: More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis
by: Özgür Yaycıoğlu
Published: (2018-09-01)

Patterns of finasteride and dutasteride use in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort: effects of socio-demographic factors and a black box warning
by: Jarrett A. Johnson, et al.
Published: (2022-01-01)

Correlation between prostate specific antigen, digital rectal examination and histology in patients with prostate cance
by: T U Mbaeri, et al.
Published: (2018-01-01)

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
by: Jonathan A. Gelfond, et al.
Published: (2022-03-01)

Re: A Prospective Study of Health-Related Quality-of-Life Outcomes for Patients with Low-Risk Prostate Cancer Managed by Active Surveillance or Radiation Therapy
by: Özgür Yaycıoğlu
Published: (2017-09-01)

Role of Prostate Specific Antigen, Digital Rectal Examination and Trans Rectal Ultrasonography in the Diagnosis of Prostate Cancer in Patients with Lower Urinary Tract Symptoms
by: Sunanda De, et al.
Published: (2014-02-01)

Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate‐specific antigen, digital rectal examination and the prostate‐specific antigen density based on digital rectal prostate volume category
by: Juan Morote, et al.
Published: (2023-05-01)

Higher insoluble fiber intake is associated with a lower risk of prostate cancer: results from the PLCO cohort
by: Yang Shen, et al.
Published: (2024-01-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Evaluation of prostatic cancer prevalence in patients with prostatic-specific antigen between 4 and 10 and normal digital rectal examination
by: Farhad Tadayon, et al.
Published: (2016-01-01)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
by: N. V. Marshutina, et al.
Published: (2016-03-01)

Patients’ reactions to digital rectal examination of the prostate
by: Udoh EA, et al.
Published: (2022-05-01)

The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer
by: Barış Kuzgunbay, et al.
Published: (2015-09-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

Digital rectal examination (DRE) does not influence total serum levels of prostate specific antigen (tPSA), in individuals without prostate pathology
by: Maria de F. Figueirêdo, et al.
Published: (2003-10-01)

Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
by: Stephanie J Weinstein, et al.
Published: (2012-01-01)

Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity
by: Nelson C. Okpua, et al.
Published: (2021-02-01)

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4–10 ng/mL and negative digital rectal examination
by: Supon Sriplakich, et al.
Published: (2018-12-01)

Recommendations of Test of Prostate-specific Antigen along with Histopathological Examination for the Prostate Lesions
by: Pallavi Gedam, et al.
Published: (2019-10-01)

Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination
by: Mesut Altan, et al.
Published: (2020-06-01)

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
by: Jeremy YC Teoh, et al.
Published: (2015-01-01)

Solitary rectal metastasis of prostate cancer resembling primary colorectal cancer
by: Yasuhiko Hamada, et al.
Published: (2021-10-01)

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
by: Juan Morote, et al.
Published: (2022-10-01)

The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
by: Zeng Zhenhao, et al.
Published: (2022-09-01)

The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume
by: Juan Morote, et al.
Published: (2024-04-01)

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
by: T. Yoneyama, et al.
Published: (2020-07-01)

Re: Causes of Hospital Readmissions after Urologic Cancer Surgery
by: Özgür Yaycıoğlu
Published: (2016-09-01)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
by: Joel Andersson, et al.
Published: (2022-10-01)

Patient positioning during digital rectal examination of the prostate: preferences, tolerability, and results
by: Frederico R. Romero, et al.
Published: (2011-06-01)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
by: Seokhwan Bang, et al.
Published: (2021-11-01)

The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes
by: Daimantas Milonas, et al.
Published: (2021-05-01)